AI In Life Science Analytics Market Size, Share Report 2025


The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Will Be the Forecast Market Size of the Global AI In Life Science Analytics Market by 2030?
The AI in life science analytics market size has grown rapidly in recent years. It will grow from $2.63 billion in 2025 to $3.13 billion in 2026 at a compound annual growth rate (CAGR) of 19.0%. The growth in the historic period can be attributed to increasing volume of clinical and research data, expansion of digital clinical trials, growing use of analytics in pharmaceutical r&d, adoption of data-driven decision making in life sciences, improvements in data integration technologies.

The AI in life science analytics market size is expected to see rapid growth in the next few years. It will grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising investments in ai-enabled drug development, expansion of cloud analytics adoption, growing use of real-world evidence analytics, increasing focus on operational efficiency in life sciences. Major trends in the forecast period include increasing deployment of ai-based clinical analytics tools, rising use of predictive modeling in drug discovery, growing adoption of cloud-based life science analytics, expansion of real-time data integration platforms, enhanced focus on actionable insight generation.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report

Which Key Growth Contributors Will Drive the AI In Life Science Analytics Market in the Next Decade?
The rising healthcare expenditure is expected to propel the growth of the g AI in the life science analytics market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specific period, encompassing various costs related to medical treatment and public health initiatives. Rising healthcare expenditure is due to the growing prevalence of chronic and lifestyle-related diseases, which require long-term treatment, ongoing medical care, and costly interventions. Healthcare expenditure drives the adoption of AI in life science analytics by funding advanced data-driven tools that improve research efficiency, patient outcomes, and cost-effective healthcare solutions. For instance, in May 2024, according to the Office of National Statistics, a UK-based government agency, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, compared with growth of 0.9% in 2022. Therefore, rising healthcare expenditure is driving the growth of AI in the life science analytics market.

What Are the Emerging Segments in the AI In Life Science Analytics Market?
The AI in life science analytics market covered in this report is segmented –

1) By Component: Software, Hardware, Services
2) By Deployment: On-Premise, Cloud
3) By Application: Research And Development, Sales And Marketing Support, Supply Chain Analytics, Other Applications
4) By End-User: Medical Devices, Pharmaceutical, Biotechnology, Other End Users

Subsegments:
1) By Software: Data Analysis Software, Predictive Analytics Tools, Machine Learning Platforms, Visualization Software, Clinical Trial Management Software
2) By Hardware: Servers, Storage Solutions, Workstations, Networking Equipment
3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Management Services, Training Services

What Are the Top Trends Expected to Shape the AI In Life Science Analytics Market by 2029?
Major companies operating in the AI in Life Science Analytics market are focusing on developing innovative solutions, such as AI empowered multi omics data analysis platforms, to accelerate insights and precision in biomedical research. An AI-empowered multi-omics data analysis platform is a technology that uses artificial intelligence to integrate and analyze diverse biological data types such as genomics, proteomics, and metabolomics to uncover complex biological insights and support precision medicine. For instance, in October 2023, BioLizard, a Belgium-based biotechnology company, launched a new AI-empowered BioVerse platform to facilitate data-driven R&D for the global life sciences community. The platform is designed to provide tailored, user-friendly software solutions for data-driven results, targeted towards scientists in biotech and pharma, with or without IT backgrounds. The platform includes three applications, such as Bio|Reflect, which provides global overviews of publications to support unbiased literature searches; Pro|Biome, which applies data analytics to microbiome analysis; and Bio|Mx, which leverages AI to integrate and analyze multi-omics datasets. The goal of BioVerse is to facilitate data-driven discovery and preclinical, translational, and clinical R&D processes in the life sciences industry by implementing AI-driven solutions. This launch demonstrates BioLizard's commitment to providing AI-driven solutions to support data-driven discovery and preclinical, translational, and clinical R&D processes in the life sciences industry.

Who Are the Top Companies Contributing to the AI In Life Science Analytics Market Expansion?
Major companies operating in the AI in life science analytics market are Indegene Limited; International Business Machines Corporation; IQVIA Holdings Inc.; Databricks Inc.; SAS Institute Inc.; Sorcero; Atomwise Inc.; Microsoft Corporation; NVIDIA Corporation; Oracle Corporation; NuMedii Inc.; Enlitic Inc.; Apixio Inc.; AiCure LLC; Google LLC; Amazon Web Services Inc.; Accenture; BioSymetrics; Cloud Pharmaceuticals; Freenome; GNS Healthcare; Insilico Medicine; PathAI; Recursion Pharmaceuticals; Sophia Genetics; Veracyte Inc.; Lexalytics Inc.; Sisense Inc.; Cognitivescale; Ayasdi; Cyrcadia Health

Get the full ai in life science analytics market report here:
https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report

Which Region Is Projected to Account for the Largest Share of the AI In Life Science Analytics Market?
North America was the largest region in the AI in life science analytics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the AI in life science analytics market report during the forecast period. The regions covered in the AI in life science analytics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Oncologists Market Scope, Share Analysis And Growth 2025

Image
Crafted for informed planning, this report explores the forces reshaping the oncologists market and what they mean for business leaders. How Big Is The Oncologists Market In 2025? The oncologists market size has grown marginally in recent years. It will grow from $19.93 billion in 2024 to $20.21 billion in 2025 at a compound annual growth rate (CAGR) of 1.4%. The growth in the historic period can be attributed to increasing cancer incidence, therapeutic advancements, aging population, healthcare infrastructure development, awareness and early detection programs. The oncologists market size is expected to see steady growth in the next few years. It will grow to $23.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, emerging therapeutic modalities, global oncology collaboration, epidemiological shifts and new challenges, healthcare policy and economic factors. Major tre...
Read more

Global Digital Photography Market Analysis, Scope And Growth Opportunities 2025 To 2034

Image
Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations What Will Be the Forecast Market Size of the Global Digital Photography Market by 2029? The digital photography market size has grown steadily in recent years. It will grow from $53.14 billion in 2024 to $55.74 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to smartphone integration, social media influence, internet connectivity, software development, and e-commerce in photography gear. The digital photography market size is expected to see strong growth in the next few years. It will grow to $70.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to artificial intelligence in imaging, virtual and augmented reality photography, subscription-based photography services, blockchain for copyright protection, and sustainability in...
Read more

Electronic Clinical Outcome Assessment Solutions Market Size, Scope And Growth 2025 To 2034

Image
Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence What Is the Predicted Market Size and CAGR of the Electronic Clinical Outcome Assessment Solutions Market by the End of the 2029? The electronic clinical outcome assessment solutions market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to regulatory support, patient-centric approach, data quality and accuracy, cost efficiency and time savings, increasing global clinical trials. The electronic clinical outcome assessment solutions market size is expected to see rapid growth in the next few years. It will grow to " $3.22 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to integration with wearable devices, decentralized and hybrid tr...
Read more